MANUFACTURING
BIOTECH INNOVATION
Scroll
PLASMID
Plasmid DNA development and manufacturing for viral vector and mRNA production
ANEMOCYTE MEANS TALENTS
Here at Anemocyte, we support, value and inspire those with a vision of a different world.
NEWS & EVENTS
Advancing mRNA Science – We’re Attending the mRNA-Based Therapeutics Summit in Boston
From July 21st to 23rd, 2025, Boston will host one of the most influential gatherings in the field of mRNA...
Anemocyte alongside Alliance for Regenerative Medicine (ARM)
We're among the Alliance for Regenerative Medicine (ARM) leaders calling on the EU to act for the future of advanced...
Anemocyte is heading to Boston!
We’re excited to announce our participation in the BIO International Convention 2025, taking place from June 16–19 at the Boston...
Anemocyte at AFI’s symposium in Rimini
We are thrilled to announce our participation in the 64th AFI Symposium, taking place from June 11 to 13, 2025,...
Anemocyte is thrilled to announce its participation in the upcoming international conference on gene therapy
Anemocyte, a biotech company at the forefront of advanced therapy development, is excited to join the upcoming international conference on...
Altheia Science and Anemocyte: A Strategic Alliance Accelerating the Future of Cell & Gene Therapies
Altheia Science proudly announces the success of its strategic collaboration with Anemocyte, a leading developer and manufacturer of pDNA and...
MANUFACTURING
BIOTECH
INNOVATION
PLASMID
Plasmid DNA development and manufacturing for viral vector and mRNA production
ANEMOCYTE MEANS TALENTS
Here at Anemocyte, we support, value and inspire those with a vision of a different world.
NEWS & EVENTS
Advancing mRNA Science – We’re Attending the mRNA-Based Therapeutics Summit in Boston
From July 21st to 23rd, 2025, Boston will host one of the most influential gatherings in the field of mRNA...
Anemocyte alongside Alliance for Regenerative Medicine (ARM)
We're among the Alliance for Regenerative Medicine (ARM) leaders calling on the EU to act for the future of advanced...
Anemocyte is heading to Boston!
We’re excited to announce our participation in the BIO International Convention 2025, taking place from June 16–19 at the Boston...
Anemocyte at AFI’s symposium in Rimini
We are thrilled to announce our participation in the 64th AFI Symposium, taking place from June 11 to 13, 2025,...
Anemocyte is thrilled to announce its participation in the upcoming international conference on gene therapy
Anemocyte, a biotech company at the forefront of advanced therapy development, is excited to join the upcoming international conference on...
Altheia Science and Anemocyte: A Strategic Alliance Accelerating the Future of Cell & Gene Therapies
Altheia Science proudly announces the success of its strategic collaboration with Anemocyte, a leading developer and manufacturer of pDNA and...
